Chip Kahn is stepping down after almost 25 years at the for-profit hospital association. He’ll be replaced by Charlene MacDonald, who leads lobbying and public affairs for the FAH.
Federation of American Hospitals names CEO to replace retiring veteran Read More »
George Renaudin, who has been with Humana for almost 30 years, is retiring, the insurer announced Tuesday. Aaron Martin, previously Amazon’s vice president of healthcare, will take his place.
Humana taps ex-Amazon executive as incoming insurance head Read More »
BMS is Harbour’s second powerhouse partner this year after the Chinese biotech signed a potential $4.68 billion deal with AstraZeneca in March.
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour Read More »
X9 is building an ultrasound-guided device used to simplify the process of inserting a needle for cannulation.
Dialysis cannulation can be difficult. A startup is working to improve it. Read More »
Thirteen medical centers are scheduled to go live with the Oracle EHR next year. But the embattled project hasn’t fully implemented most recommendations from the Government Accountability Office.
Lawmakers worry about new VA Oracle EHR rollouts Read More »
The influential senator pressed 10 health IT and EHR firms to implement features that give patients more control over the flow of their health data.
Wyden pushes EHR vendors to adopt data privacy features Read More »
La ceguera es una de las discapacidades de mayor impacto en la vida de las personas. Actualmente, varios laboratorios del mundo, entre los que se encuentra el de Neuroingeniería Biomédica de la Universidad Miguel Hernández de Elche (UMH) en España, exploran las pró …
Roche CEO Thomas Schinecker said during the company’s Q3 call that it is “not done” with deals—a promise he delivered on with Tuesday’s solid tumor pact with AI-focused Caris Life Sciences.
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab Read More »
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III development.
Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg Read More »
En un avance científico que fascinará a un sector de la sociedad e inquietará a otro, y que inevitablemente a unos y otros les recordará la historia de Frankenstein creada por la novelista Mary Shelley y descrita en muchas películas, unos científicos han con …
